These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35434)

  • 1. Serum levels of pancreatic polypeptide in Zollinger-Ellison syndrome, and hyperparthyroidism from families with multiple endocrine adenomatosis type I.
    Lamers CB; Diemel J; Roeffen W
    Digestion; 1978; 18(5-6):297-302. PubMed ID: 35434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperparathyroidism associated with Zollinger-Ellison syndrome. 4 cases (author's transl)].
    Rigaud D; Bauer P; Hervoir P; Fasano JJ; Moreau J; Mignon M; Bonfils S
    Nouv Presse Med; 1982 Apr; 11(17):1299-303. PubMed ID: 6123105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I.
    Oberg K; Wälinder O; Boström H; Lundqvist G; Wide L
    Am J Med; 1982 Nov; 73(5):619-30. PubMed ID: 6127949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.
    Betts JB; O'Malley BP; Rosenthal FD
    Q J Med; 1980; 49(193):69-76. PubMed ID: 6107954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
    Rigaud D; Accary JP; Mignon M; Bonfils S
    Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postatropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I.
    Lamers CB; Diemel CM
    J Clin Endocrinol Metab; 1982 Oct; 55(4):774-8. PubMed ID: 7107820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergastrinemia in familial multiple endocrine adenomatosis.
    Synder N; Scurry M; Hughes W
    Ann Intern Med; 1974 Mar; 80(3):321-5. PubMed ID: 4150177
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia.
    Lamers CB; Hackeng WH; Thien T; van Tongeren JH
    Digestion; 1980; 20(6):379-82. PubMed ID: 6105986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypergastrinemia. Physiopathological and clinical aspects with a study of a series of Zollinger-Ellison cases].
    Fiasse R; De Graef J; Pauwels S; Woussen-Colle MC; Rahier J; Kestens PJ; Dive C
    Acta Gastroenterol Belg; 1982; 45(7-8):293-309. PubMed ID: 6132512
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome.
    Chiang HC; O'Dorisio TM; Huang SC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1990 Dec; 99(6):1565-75. PubMed ID: 2227272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretin-stimulated serum gastrin levels in hyperparathyroid patients from families with multiple endocrine adenomatosis type I.
    Lamers CB; Buis JT; van Tongeren J
    Ann Intern Med; 1977 Jun; 86(6):719-24. PubMed ID: 17340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
    Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zollinger-Ellison syndrome: a clinical update.
    Marshall JB; Settles RH
    Postgrad Med; 1980 Jul; 68(1):38-41, 45-6, 49-50. PubMed ID: 7393784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.
    Norton JA; Cornelius MJ; Doppman JL; Maton PN; Gardner JD; Jensen RT
    Surgery; 1987 Dec; 102(6):958-66. PubMed ID: 2891201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic-polypeptide (PP) and endocrine tumours of the pancreas.
    Schwartz TW
    Scand J Gastroenterol Suppl; 1979; 53():93-100. PubMed ID: 225793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological diagnosis of Zollinger-Ellison syndrome in the context of a polyendocrine adenomatosis].
    Bonfils S; Bernades P; Letonturier P
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2027-31. PubMed ID: 241055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial multiple endocrine adenomatosis type I (MEAS I) (author's transl)].
    Pumarino H; Csendes A; Vivanco N; Stevenson C; Pineda G
    Rev Med Chil; 1980 Mar; 108(3):221-32. PubMed ID: 6107969
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of initial fasting serum gastrin levels in patients with Zollinger-Ellison syndrome.
    Berger AC; Gibril F; Venzon DJ; Doppman JL; Norton JA; Bartlett DL; Libutti SK; Jensen RT; Alexander HR
    J Clin Oncol; 2001 Jun; 19(12):3051-7. PubMed ID: 11408501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
    Singh Ospina N; Donegan D; Rodriguez-Gutierrez R; Al-Hilli Z; Young WF
    Am J Med; 2017 May; 130(5):603-605. PubMed ID: 28011308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pancreatic polypeptide response to secretin.
    Peracchi M; Tagliabue R; Quatrini M; Reschini E
    Eur J Endocrinol; 1999 Jul; 141(1):47-9. PubMed ID: 10407222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.